Formula milk companies push allergy products despite flawed evidence
- PMID: 35296503
- PMCID: PMC9879268
- DOI: 10.1136/bmj.o630
Formula milk companies push allergy products despite flawed evidence
Abstract
Europe has toughened its approach to formula milk products that claim to reduce allergy risks. But consumers elsewhere continue to be coaxed into buying products that make health claims without high quality evidence. Melanie Newman reports
Conflict of interest statement
Competing interests: None declared.
References
-
- FTSE Russell. FTSE4Good inclusion criteria for the marketing of breast milk substitutes. Jul 2017. https://research.ftserussell.com/products/downloads/F4G_BMS_Criteria.pdf
-
- Federal Trade Commission. Gerber Products Co, doing business as Nestlé Nutrition, et al. Updated 15 Jul 2019. https://www.ftc.gov/enforcement/cases-proceedings/132-3009-x150016/gerbe...
-
- Castenmiller J, Hirsch-Ernst K-I, Kearney, et al; EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). Scientific opinion on the efficacy of an infant formula manufactured from a specific protein hydrolysate derived from whey protein isolate and concentrate produced by Société des Produits Nestlé SA in reducing the risk of developing atopic dermatitis. EFSA J 2021;19:6603. https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2021.6603 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources